has partnered with
April 2024
William Blair acted as the exclusive financial advisor to TT medic GmbH and its shareholders in connection with entering a partnership with Trill Impact.
Read moreManaging Director, Healthcare Services, Head of Frankfurt Office
Moritz-Benedikt Rottwinkel is a managing director for William Blair based in the firm’s Frankfurt office. He joined William Blair's investment banking team in 2012. Prior to William Blair, he worked for SEB Enskilda Corporate Finance and Lincoln International.
German
English
has partnered with
April 2024
William Blair acted as the exclusive financial advisor to TT medic GmbH and its shareholders in connection with entering a partnership with Trill Impact.
Read morehas been acquired by
October 2022
William Blair acted as the exclusive financial advisor to CEVEC Pharmaceuticals in connection with its sale to Danaher Corporation (NYSE: DHR) and its portfolio company Cytiva.
Read morea portfolio company of International Chemical Investors Group
has been acquired by
August 2022
William Blair acted as the exclusive financial advisor to International Chemical Investors Group in connection with its pending sale of its portfolio company, CordenPharma, to Astorg.
Read morehas been acquired by
February 2022
has been acquired by
October 2021
William Blair acted as financial advisor to Hemovent, a company backed by a consortium of institutional investors led by MIG Capital in connection with its sale to MicroPort (SEHK Ticker: 0853) for €123m in total consideration (including future milestone payments).
Read morea portfolio company of
Water Street Healthcare Partners
has been acquired by
a portfolio company of CVC Capital Partners, Téthys Invest and CDPQ
September 2021
has been acquired by
August 2021
William Blair acted as the exclusive financial advisor to evitria, a portfolio company of Afinum Management and SHS Capital, in connection with its sale to Atlas Antibodies, a portfolio company of Patricia Industries.
Read morehas sold its facility in Couvet, Switzerland to
July 2021
Sartorius Stedim Biotech GmbH
has acquired
November 2020
has been acquired by
December 2019
has been acquired by
January 2020
has sold its manufacturing facility in Anagni, Italy to
December 2019
Our investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William BlairWilliam Blair’s Healthcare Services team is a trusted partner to providers, suppliers, and solutions providers across the healthcare continuum. Our knowledge of emerging healthcare trends and the nuances of reimbursement models have allowed us to help clients access capital and form valuable strategic partnerships.
More about our healthcare services expertiseWilliam Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*
Year William Blair was founded
Employees worldwide
Client assets
Independent and employee-owned
Offices worldwide
Companies under coverage
As of September 30, 2024
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.
This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.
Copyright © 2024 William Blair & Company, L.L.C. | Privacy Terms
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures